CD274 and non-small cell lung carcinoma: Studies that investigated the use of immunotherapy (IO) in patients diagnosed with lung cancer without previous history of smoking have shown conflicting results, despite PD-L1 expression, and smoking history has been proposed as a biomarker associated with response to this therapy in NSCLC (69).